Detect C3d-binding donor-specific anti-HLA antibodies (DSAs) for better risk stratification of patients.
The LIFECODES C3d Assay provides a measure of the binding and processing of complement to one of its end products - C3d. When combined with our LIFECODES LSA Single Antigen Kits, the assay offers a simple method for the detection of complement binding to HLA antibodies.
- Identifies complement binding antibodies
- Streamlines work flow with MATCH IT!® Antibody software
- Utilizes highly sensitive Luminex® xMAP® technology
Product offerings may differ by region, please check with your local Immucor representative for regulatory status in your area.
Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory, USA
Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network, USA
Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia, USA
Webinars & Workshops
Effect of HLA class I signal peptide variation on HLA-E expression and natural killer cell function
October 14th 2022
ASHI Annual Meeting 2022
October 24th 2022
Immunohematology Wet Workshop - Arkansas, USA
November 2nd 2022